Skip to main content

Table 1 Polymer material composition of each formulation

From: Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

Formulation

mPEG-PLGA (75/25)

PLGA (50/50)

PLGA (75/25)

PLGA-PEG-PLGA (50/50)

PLGA-PEG-PLGA (75/25)

F1

20 mg

–

–

–

–

F2

–

20 mg

–

–

–

F3

–

–

20 mg

–

–

F4

–

–

–

20 mg

–

F5

–

–

–

–

20 mg

F6

10 mg

10 mg

–

–

–

F7

10 mg

–

10 mg

–

–